PRMT6 suppresses TSP-1 transcription by altering H3R2 and H3K4 methylation at its promoter in breast, prostate, and osteosarcoma cells, thereby facilitating tumor angiogenesis [373, 374]. This evidence concerns the gene PRMT6 and neoplasm.